{"name":"Stuart Therapeutics, Inc.","slug":"stuart-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQa1EzVDFkU3FmY1VUajZ6ZXhnVnBNTjdURXNES3dsRVpYNDlRU1dweUg1Y3lIZ2ZueDhsTFo2anE2dHIyeHhFX1NDUU5pdUtBV3VFdl9vOUNCcU9NejhKZUJnY21jdy1ISFNrYWxYSlVWZl9kX1l1c2hVdUZfVlhaSUtWTDM4MHBzbTFiU3lBdFRDQkkz?oc=5","date":"2026-04-06","type":"trial","source":"openPR.com","summary":"Allergic Conjunctivitis Clinical Trials Landscape 2026: - openPR.com","headline":"Allergic Conjunctivitis Clinical Trials Landscape 2026:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQLW0wY2NCNmt4N1JMQ2R5MXVPdmxiV09BLXc5Ul9oYk5WUm9KOFFneTNYNnhaVTF1QmxzbS1YX3FXUENjNmViQVp1LXA3QlZKOVhaM1lScU9rRHhpcFVMUVhPdC1WWFVjWEJQbEFsUzFjV0pzVjMteGhOZ0hqbjN0RTZ1YUxlcGM4VVd1RVhYc0xiZ21zb01tWlVZRE0?oc=5","date":"2025-12-03","type":"pipeline","source":"citybiz","summary":"Alnylam Pharmaceuticals Appoints Stuart Arbuckle To Board - citybiz","headline":"Alnylam Pharmaceuticals Appoints Stuart Arbuckle To Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOTUpHcnZ5SUhfZmNmajBRUVRJMGFKSHh4T1I5cWhNYm5tdHFfa0dXeVhNcllnd25HTUN0MzRVYmRlNk42RHpoTGdnUXNUd25JendEUUJWRnUzbGIwdXltRGxwR0pURGFKWGU3RU5xRE91d0tIdElhSWxxTUJvUHdDS3dMNjI1Z0s4ak41ZlFYWVlyZXpxai1Weg?oc=5","date":"2025-12-03","type":"pipeline","source":"Yahoo Finance","summary":"Alnylam Pharmaceuticals Announces Changes to Board of Directors - Yahoo Finance","headline":"Alnylam Pharmaceuticals Announces Changes to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxQVzZFUzFrZHRPSThjMGkwZngtNl9uNkhRNzlUX2VZbTFMTWo4Mi1aOExYSXVjRU5tVl9FTVVmRVJpM3pwbGx1N0FDcnRoVUJrT2o4YW4xZEdDa0FJU3dxSjhvbUhrTEt3MG04bkV0UE1WckdMdHViQ2lnVzJySmdaZUZjUFQ4YW5SWDFPS2lxQ3VYUHFIdVRRTGM4UldGMnlnWUlOQkVjWWppMzdHOHpZLTdoMmZzTXJKZXptd01QQllfZEg2clRqc3ptV0xDX2NEeHB2TVo1VWhTU2FacTM3WEFDUTNyNUkwbkgtU1JJdmxoamJBMlVwVkx0d1dianVQUjhoQ0cwaE9WM3pTRVhZelNoMk1QRGM1alMxcG5TRFotUnRVRkZHRThsOWpUMHZOamc?oc=5","date":"2025-06-24","type":"trial","source":"PR Newswire","summary":"Stuart Therapeutics Announces Initial Results of Phase III Clinical Trial for ST-100 (Vezocolmitide) Ophthalmic Solution, a Novel Dry Eye Disease Candidate - PR Newswire","headline":"Stuart Therapeutics Announces Initial Results of Phase III Clinical Trial for ST-100 (Vezocolmitide) Ophthalmic Solution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxPa2NIQ3N6S3EzX0NyS200bzhURi1KUnNEc01tRzR4MGNpQU1IdjBlZDQ3NWx2NmtlcXM0NWpYT3pfWHhlMGFqTFlxNzRYUGVYREo1MmI5NGlLUHNoUXk2MThpcllLSHRYZWgyY2dXTF9JNWplbmFXZXZjNGNCUGlDbmRwaThQWFQtd2cwRG5wV3h2eW9lX1hBYVVUUnBrWlZVNTVqd0ZnMzhCSE12MWZVdHZfTjdSQnN0cWtGdzJMbGhldWtZVHBJN2I2OHV5ck5mVVc0a2NxY1lnZmYtbVdUQ1NrVEtDeHd3U0tZUVhtWjdvZnFFLU9GVUZrOVU2VGZKQVozdnI4eEE1bFhxMzlQckhLRWVaV0QydUE?oc=5","date":"2025-06-10","type":"pipeline","source":"Business Wire","summary":"Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseases - Business Wire","headline":"Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOT0EycFJoandpRnVOMlJMQkpDVmpmNWNuRGhnN05OT3FGOUxRaks4aTVSTUNkOHpxR1RqZW9LMUZya2Q0ZEVnU0xvYkM2ZTRFOFhPVGZDMURxWVpXem5Pc1hKWVkxem04Sm5adEgzeEswM1NBQ1Zzd0ttTm1CemRRZnhGMW9KOUJXQnk5Qnk0LTE0bXc5NTJOWmg3TkkyZHhZY3gwZ1FpNTZsMU00ZVN0UFJXQ0paNndWRkdHRWg3Z1FZZHJkb2JOUXNoaW91bk9mNGdr?oc=5","date":"2025-04-01","type":"pipeline","source":"Business Wire","summary":"Nuage Therapeutics appoints Dr. Stuart Hughes as CEO and Vanessa Malier as Chair - Business Wire","headline":"Nuage Therapeutics appoints Dr. Stuart Hughes as CEO and Vanessa Malier as Chair","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQX0FhUXQ3a3hYSThheWt4Uk1KemU1djJIbEdGME44cWoyemRtQnlrZno3c05BUFNKVlB2cnBnMGV1QURZdXBDT05vMmtTSTRGN3pFQzZVNHVqT1RVNC1lbG1ZSmdUaGp6LWtsaVRaT1hKVjVoaFladmx1ekU0eDRHWEhqX1NzRjR4NUt6N1NQTDhfS0JQZ2RISV9FdzVlS3JEZ05RRmx0b2VZR2c0TGllbTVsOG9yOF9oc1cyVWl6ak1LYTM0TWlhOHplT0FkTnVWYUl2bA?oc=5","date":"2025-01-21","type":"trial","source":"PR Newswire","summary":"Stuart Therapeutics Announces Completion of Phase 3 Dry Eye Disease Clinical Trial - PR Newswire","headline":"Stuart Therapeutics Announces Completion of Phase 3 Dry Eye Disease Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQTFR6bS1tdXdYVjgwWGpGQlRDQVpmMVMyR2l3NjhmUUxPXzJqdGx6b2prZmpKS0RlVHlWWGx1TlcwN0lrNGdxRVROLWxwYVNEVjlXU3NPRTBPc09LclhxNkJMbklhTS0xNTladjNSY0EyZTdENm1TcXdsYzBWU2JKdi1mOExQZERKbTlvR1J1bXo3cWRnbmJzaGxIUVdHZjhiSzc3OG4xNEVjR0xmelcxcVdySUFwb1ZTWXNTc0xHbHkzejhB?oc=5","date":"2024-12-22","type":"pipeline","source":"PR Newswire","summary":"Stuart Therapeutics Announces the Appointment of Two New Board Members - PR Newswire","headline":"Stuart Therapeutics Announces the Appointment of Two New Board Members","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOQ0Fsd0QtUG9WMjFRLWEtRGxSUkVJUTA2R2ZZN2IwbTRYeklyZ0JGODN6aWZ0cERseU9ad1Jxb3ZNTjBucHFuTzJVTlBTTkxfWi1jMFlKSEZMajJ3dFBYRWptbWJPV0tlYkdmQmVxcE9uZF9aR0QxNXFtRHN3eFlPeEJRMGZLM2hmOVR5NkxuSl95T09fSVppOXAxUnAtMWt3Y2RvZkxOQmhWMTlRRzYwVlNrMjJOb3hkOFI3NjF2VEVxZGs?oc=5","date":"2024-07-25","type":"pipeline","source":"Contract Pharma","summary":"Stuart Therapeutics Taps Dr. Lukas Scheibler as Chief Science & Technology Officer - Contract Pharma","headline":"Stuart Therapeutics Taps Dr. Lukas Scheibler as Chief Science & Technology Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPbDJ1TzQ1YnZ5QzlER2xUMENBWVVXaFpTb3lQb0VfV3QyTWhWR3JMUkVXVWJROHhqMTUxMXdKYzQ2VThtVGc3V0FNV2hNai1jNS0wS0xGUWhKbTB0bW4xbG5hWnVQLWFvX250TkY5OXYwS25FMER3Z1BnUXQ2VmJfVVA5R20wU2czc1MydHdYeVhYbUxJQjFSUGdTbXVVdUxwdmc?oc=5","date":"2024-03-13","type":"pipeline","source":"European Medical Journal","summary":"5 minutes with Stuart Peltz, former CEO, PTC Therapeutics - European Medical Journal","headline":"5 minutes with Stuart Peltz, former CEO, PTC Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNS1Y3WHBTMHBHSm44VTMwVzNlMHlMX3ptT0NGZEs3Zl9ZVDIxRk1ja0VwQkV5eXRhMGt3RWNxLVhSUWhhUnNFRHNkX241Z1FHaUE4Rm9MeWgyb0dsQ3p0c0ViV2RZeUdiSGcyXzYyMzh1SmdKNHRhTkNpLWRkaXRfTTFnajltVjNfVnVldG5XeVJ3Y2Y5clMxY2FKSDExY21Ed1BaQjY4OTI1a1dNTHg3bl9FZmZVQQ?oc=5","date":"2022-07-21","type":"regulatory","source":"Florida Hospital News and Healthcare Report","summary":"Stuart Therapeutics Announces Successful Outcome from Type C Meeting with FDA - Florida Hospital News and Healthcare Report","headline":"Stuart Therapeutics Announces Successful Outcome from Type C Meeting with FDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNbjVsUkFLTURpYUhIN2RQQWRESmNzVF9tWGRodHhjSnZtM084eTZRNDB4ZkpEN29yVjBOZS1jZnBEVnRJX3JMbE90em53clRHWENoS0tvQVlNWmtrcmY2YlREbEJkMmdBN0lScUZsNUJva2s4MmFKRExjZUhUeUJpSEpQaEdnY0lPVkE4Mk5fQUhHNXJGbnczdlp1Q08?oc=5","date":"2022-05-02","type":"pipeline","source":"Ventus Therapeutics","summary":"Ventus Therapeutics Appoints Stuart Green, M.D., as Chief Medical Officer - Ventus Therapeutics","headline":"Ventus Therapeutics Appoints Stuart Green, M.D., as Chief Medical Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}